"Organometallic Compounds" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class of compounds of the type R-M, where a C atom is joined directly to any other element except H, C, N, O, F, Cl, Br, I, or At. (Grant & Hackh's Chemical Dictionary, 5th ed)
| Descriptor ID |
D009942
|
| MeSH Number(s) |
D02.691
|
| Concept/Terms |
Organometallic Compounds- Organometallic Compounds
- Compounds, Organometallic
- Metallo-Organic Compounds
- Compounds, Metallo-Organic
- Metallo Organic Compounds
- Metalloorganic Compounds
- Compounds, Metalloorganic
|
Below are MeSH descriptors whose meaning is more general than "Organometallic Compounds".
Below are MeSH descriptors whose meaning is more specific than "Organometallic Compounds".
This graph shows the total number of publications written about "Organometallic Compounds" by people in this website by year, and whether "Organometallic Compounds" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1997 | 2 | 1 | 3 |
| 1999 | 0 | 2 | 2 |
| 2000 | 0 | 1 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 2 | 0 | 2 |
| 2003 | 2 | 2 | 4 |
| 2004 | 1 | 3 | 4 |
| 2005 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 3 | 0 | 3 |
| 2009 | 3 | 0 | 3 |
| 2010 | 0 | 2 | 2 |
| 2011 | 1 | 2 | 3 |
| 2012 | 2 | 0 | 2 |
| 2013 | 4 | 1 | 5 |
| 2014 | 3 | 1 | 4 |
| 2015 | 3 | 1 | 4 |
| 2016 | 0 | 2 | 2 |
| 2017 | 1 | 1 | 2 |
| 2018 | 4 | 2 | 6 |
| 2019 | 0 | 2 | 2 |
| 2020 | 1 | 1 | 2 |
| 2021 | 1 | 1 | 2 |
| 2024 | 4 | 1 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Organometallic Compounds" by people in Profiles.
-
A liposomal Gd contrast agent does not cross the mouse placental barrier. Sci Rep. 2016 06 14; 6:27863.
-
Advancing pharmacovigilance through academic-legal collaboration: the case of gadolinium-based contrast agents and nephrogenic systemic fibrosis-a Research on Adverse Drug Events and Reports (RADAR) report. Br J Radiol. 2014 Oct; 87(1042):20140307.
-
Intranasal delivery of mesenchymal stem cells significantly extends survival of irradiated mice with experimental brain tumors. Mol Ther. 2014 Jan; 22(1):140-8.
-
Comparison of antimicrobial activity of zinc chloride and bismuth subsalicylate against clinical isolates of Helicobacter pylori. Microb Drug Resist. 2014 Aug; 20(4):305-9.
-
Performance of spin-echo and gradient-echo T1-weighted sequences for evaluation of dural venous sinus thrombosis and stenosis. AJR Am J Roentgenol. 2013 Jul; 201(1):162-9.
-
Small-animal PET of tumor damage induced by photothermal ablation with 64Cu-bis-DOTA-hypericin. J Nucl Med. 2011 May; 52(5):792-9.
-
Controlling peptide structure with coordination chemistry: robust and reversible peptide-dirhodium ligation. Chemistry. 2009 Sep 14; 15(36):8961-5.
-
Phase I study of concurrent weekly docetaxel and repeated samarium-153 lexidronam in patients with castration-resistant metastatic prostate cancer. J Clin Oncol. 2009 Jul 10; 27(20):3319-24.
-
Three-dimensional fast spoiled gradient-echo dual echo (3D-FSPGR-DE) with water reconstruction: preliminary experience with a novel pulse sequence for gadolinium-enhanced abdominal MR imaging. J Magn Reson Imaging. 2008 Oct; 28(4):946-56.
-
Activation of Nrf2 by arsenite and monomethylarsonous acid is independent of Keap1-C151: enhanced Keap1-Cul3 interaction. Toxicol Appl Pharmacol. 2008 Aug 01; 230(3):383-9.